IP Library Patent Application 12711553
Patent Application
App. No. 12/711,553

LOW VISCOSITY PHOSPHOLIPID COMPOSITIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/711,553
Abstract

The invention relates to processing crustaceans such as krill to oils comprising phospholipids that are Newtonian fluids and/or and have low viscosity, and in particular to the production of oils containing astaxanthin and phospholipids that show Newtonian fluidity and have a low viscosity.

Claims (19)

1 . An oil extracted from krill comprising from about 40% to about 60% phospholipids by weight of said oil and about 1 to about 1500 mg/l astaxanthin, said oil having Newtonian fluidity at 25° C.

2 . The oil of claim 1 , said oil having a viscosity of about 400 to about 1200 microPascals/sec at 25° C.

3 . The oil of claim 1 , further comprising about 35% to about 55% w/w triglycerides.

4 . The oil of claim 1 , further comprising about 10% to about 35% w/w omega-3 fatty acid residues.

5 . The oil of claim 1 , wherein said phospholipids comprise about greater than 90% phosphatidyl choline by weight of said phospholipids.

6 . The oil of claim 1 , said oil having a viscosity of about 800 to about 1100 microPascals/sec at 25° C.

7 . The oil of claim 1 , wherein said krill is Euphausia superba.

8 . A capsule containing the oil of claim 1 .

9 . The capsule of claim 7 , wherein said capsule is a gel capsule.

10 . An oral dosage form comprising an oil extracted from krill comprising from about 40% to about 60% phospholipids by weight of said oil and about 1 to about 1500 mg/l astaxanthin, said oil having a viscosity of about 700 to about 1200 microPascals/sec at 25° C.

11 . The oral dosage form of claim 10 , wherein said oral dosage form is a gelcap.

12 . The oral dosage form of claim 10 , wherein said oral dosage form is a free flowing oil.

13 . An oil extracted from krill comprising from about 40% to about 60% phospholipids by weight of said oil and about 1 to about 1500 mg/l astaxanthin, said oil having a viscosity of about 400 to about 1200 microPascals/sec at 25° C.

14 . The oil of claim 13 , wherein said oil has Newtonian fluidity at 25° C.

15 . A process for producing a krill oil having Newtonian fluidity comprising:

mixing krill with water to increase the temperature of said krill to about 25 to 80° C. to form a first solid phase and a first aqueous phase comprising said phospholipids and proteins;

separating said first solid phase from said first aqueous phase;

heating said first aqueous phase to produce a phospholipid and protein concentrate; and

extracting an oil from said phospholipid and protein concentrate.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2015
From: AKER BIOMARINE AS
To: AKER BIOMARINE ANTARCTIC AS
Reel/Frame 034739/0819 →
MERGER Recorded Feb 13, 2013
From: AKER BIOMARINE ASA
To: AKER BIOMARINE AS
Reel/Frame 029802/0828 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2010
From: TILSETH, SNORRE
To: AKER BIOMARINE ASA
Reel/Frame 024169/0550 →